Close

glia-α1a

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

In HLA-DQ2-associated CD, a series of gluten epitopes have been characterized, including peptides derived from wheat subfractions (α-, β-, γ-, and ω-gliadin and low- and high-moleclular-weight glutenins) and closely related sequences in barley hordeins and rye secalins. The immunodominant wheat gluten peptide comprises two overlapping T-cell determinants (DQ2.5-glia-α1a (PFPQPELPY) and DQ2.5-glia-α2 (PQPELPYPQ)) contained within a single, protease-resistant α-gliadin 11 mer.
  • TCR Vector Products

  • TCR Cell Products

  • TCR Viral Particles

Loading...
  • Target Species:
  • TCR Clone:
  • Host Species:
  • Epitope:
  • Allele:
  • Vector Type:
CAT Product Name Target Species TCR Clone Host Species Epitope Allele Vector Type Inquiry & Datasheet
TCR-YC0456 Human anti-glia-α1a T cell receptor (1383P.A.3), pCDTCR1 Wheat 1383P.A.3 Human PFPQPELPY HLA-DQ2.5 Lentiviral vector   Add to Cart   Datasheet
TCR-YC0457 Human anti-glia-α1a T cell receptor (1383P.A.4), pCDTCR1 Wheat 1383P.A.4 Human PFPQPELPY HLA-DQ2.5 Lentiviral vector   Add to Cart   Datasheet
TCR-YC0458 Human anti-glia-α1a T cell receptor (442D.A.45), pCDTCR1 Wheat 442D.A.45 Human PFPQPELPY HLA-DQ2.5 Lentiviral vector   Add to Cart   Datasheet
TCR-YC0459 Human anti-glia-α1a T cell receptor (S2), pCDTCR1 Wheat S2 Human glia-α1a HLA-DQ2.5 Lentiviral vector   Add to Cart   Datasheet
TCR-YC0460 Human anti-glia-α1a T cell receptor (S2.8), pCDTCR1 Wheat S2.8 Human glia-α1a HLA-DQ2.5 Lentiviral vector   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.